15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged sword

10Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

15-lipoxygenase is one of the key enzymes for the metabolism of unsaturated fatty acids that its manipulation has been proposed recently as a new molecular target for regulating cancer cell growth. Aberrant expression of 15-lipoxygenase enzyme seems to play an indicative role in the pathology of different cancer types, tumor progression, metastasis, or apoptosis. Based on the fact that breast cancer is one of the most common cancers that imposes a burden of mortality in women also, on the other hand, evidence in experimental models and human studies indicate the emerging role of the 15-lipoxygenase pathway in breast cancer pathogenesis, we present a review of recent findings related to the role of 15- lipoxygenase enzyme and metabolites in breast cancer growth, apoptosis, metastasis, and invasion as well as their local and circulating expression pattern in patients with breast cancer. Our review supports the emerging role of 15- lipoxygenase in molecular and cellular processes regulating breast tumor cell fate with both positive and negative effects.

Cite

CITATION STYLE

APA

Vaezi, M. A., Safizadeh, B., Eghtedari, A. R., Ghorbanhosseini, S. S., Rastegar, M., Salimi, V., & Tavakoli-Yaraki, M. (2021, December 1). 15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged sword. Lipids in Health and Disease. BioMed Central Ltd. https://doi.org/10.1186/s12944-021-01599-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free